T2 Biosystems (NASDAQ:TTOO) reported quarterly losses of $(1.41) per share which beat the analyst consensus estimate of $(1.70) by 17.06 percent. This is a 59.71 percent increase over losses of $(3.50) per share from the same period last year. The company reported quarterly sales of $5.48 million which beat the analyst consensus estimate of $5.40 million by 1.54 percent. This is a 21.45 percent decrease over sales of $6.98 million the same period last year.
SQZ Biotech’s Cancer Candidate Shows Response At Low Dose In HPV16+ Solid Tumor Patient
SQZ Biotechnologies Company (NYSE:SQZ) announced that a confirmed complete response was observed in the first patient in the lowest-dose cohort of…
